Moss, MD, R. B.; Carleton, PhD, F.; Lollo, PhD, C. P.; Carlo, PhD, D. J. An Open-Label, Randomized, Single-Dose, Two-Period, Two-Treatment Crossover Bioavailability Study Comparing 5 mg/0.5 ML of Intramuscular Naloxone Hydrochloride to 2 mg/0.4 ML Intramuscular Naloxone Hydrochloride Autoinjector in Healthy Subjects. J of Opioid Management 2020, 16, 209-214.